Impruvon, Inc. — Form D
Impruvon, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-05. The offering totals $2.5M, of which $2.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-02-05
- Form: D
- Accession: 0002052407-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.4M
- Remaining: $85K
- Investors: 14
- Date of first sale: 2024-11-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-537357
Issuer
- Name: Impruvon, Inc.
- CIK: 0002052407
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2101 E. BIDDLE STREET, BALTIMORE, MD, 21213
- Phone: 410-818-7272
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Justin Amoyal | Director | Baltimore, MD |
| Matthew Brezina | Director | San Francisco, CA |
| Christopher College | Director | Baltimore, MD |
| Justin Amoyal | Executive Officer | Baltimore, MD |
| Justin Amoyal | Promoter | Baltimore, MD |
More